Keita Sakamoto
YOU?
Author Swipe
View article: Comparative evaluation of four reconstruction techniques for prostate T2-weighted MRI: Sensitivity encoding, compressed sensing, deep learning, and super-resolution
Comparative evaluation of four reconstruction techniques for prostate T2-weighted MRI: Sensitivity encoding, compressed sensing, deep learning, and super-resolution Open
View article: Lymphangiomatosis diagnosed using transbronchial lung cryobiopsy: A case report
Lymphangiomatosis diagnosed using transbronchial lung cryobiopsy: A case report Open
Lymphangiomatosis, a rare systemic condition characterized by abnormally dilated lymphatic structures affecting multiple organs, is typically diagnosed using surgical lung biopsy or lymphangiography, both of which present significant techn…
View article: Comparative Evaluation of Four Reconstruction Techniques for Prostate T2-Weighted MRI: Sensitivity Encoding, Compressed Sensing, Deep Learning, and Super-Resolution
Comparative Evaluation of Four Reconstruction Techniques for Prostate T2-Weighted MRI: Sensitivity Encoding, Compressed Sensing, Deep Learning, and Super-Resolution Open
View article: Enhancing the image quality of prostate diffusion-weighted imaging in patients with prostate cancer through model-based deep learning reconstruction
Enhancing the image quality of prostate diffusion-weighted imaging in patients with prostate cancer through model-based deep learning reconstruction Open
View article: Gastrointestinal: Solid pseudopapillary neoplasm of the pancreas with high‐grade malignant transformation
Gastrointestinal: Solid pseudopapillary neoplasm of the pancreas with high‐grade malignant transformation Open
A 64-year-old man undergoing postoperative follow-up for colon cancer was incidentally found to have a 40-mm pancreatic head mass on a computed tomography (CT) scan (Fig. 1a). The tumor had increased in size over the past 12 months of foll…
View article: Two cases of airway-centered fibroelastosis treated with an antifibrotic agent and corticosteroids
Two cases of airway-centered fibroelastosis treated with an antifibrotic agent and corticosteroids Open
Airway-centered fibroelastosis is characterized by peribronchovascular fibroelastosis, predominantly in the upper lobes, with little-to-no pleural involvement. In this study, we describe two cases of airway-centered fibroelastosis diagnose…
View article: Mixed Connective Tissue Disease Complicated with Pulmonary Hypertension in Which Respiratory Failure Was Exacerbated by Pregnancy and Delivery: A Case Report
Mixed Connective Tissue Disease Complicated with Pulmonary Hypertension in Which Respiratory Failure Was Exacerbated by Pregnancy and Delivery: A Case Report Open
The prognosis for mixed connective tissue disease (MCTD) cases complicated with pulmonary hypertension (PH) remains poor. We report a case of MCTD complicated with PH in which respiratory failure was exacerbated by pregnancy and delivery. …
View article: Clinical utility of single-shot echo-planar diffusion-weighted imaging using L1-regularized iterative sensitivity encoding in prostate MRI
Clinical utility of single-shot echo-planar diffusion-weighted imaging using L1-regularized iterative sensitivity encoding in prostate MRI Open
We investigated the ability of echo-planar imaging with L1-regularized iterative sensitivity encoding-based diffusion-weighted imaging (DWI) to improve the image quality and reduce the scanning time in prostate magnetic resonance imaging. …
View article: Data from An Imbalance in TAZ and YAP Expression in Hepatocellular Carcinoma Confers Cancer Stem Cell–like Behaviors Contributing to Disease Progression
Data from An Imbalance in TAZ and YAP Expression in Hepatocellular Carcinoma Confers Cancer Stem Cell–like Behaviors Contributing to Disease Progression Open
Transcriptional coactivator with PDZ-binding motif (TAZ) and yes-associated protein (YAP) are equivalently placed downstream effectors of the Hippo pathway with oncogenic roles in human cancers. However, the expression profiles of TAZ/YAP …
View article: Supplemental figure 4 from An Imbalance in TAZ and YAP Expression in Hepatocellular Carcinoma Confers Cancer Stem Cell–like Behaviors Contributing to Disease Progression
Supplemental figure 4 from An Imbalance in TAZ and YAP Expression in Hepatocellular Carcinoma Confers Cancer Stem Cell–like Behaviors Contributing to Disease Progression Open
YAP knockdown in other gastrointestinal cancer cells (SW620 and TE-1 cells) with high YAP expression.
View article: Supplementary Figure Legends from An Imbalance in TAZ and YAP Expression in Hepatocellular Carcinoma Confers Cancer Stem Cell–like Behaviors Contributing to Disease Progression
Supplementary Figure Legends from An Imbalance in TAZ and YAP Expression in Hepatocellular Carcinoma Confers Cancer Stem Cell–like Behaviors Contributing to Disease Progression Open
Supplementary Figure Legends
View article: Supplemental figure 2 from An Imbalance in TAZ and YAP Expression in Hepatocellular Carcinoma Confers Cancer Stem Cell–like Behaviors Contributing to Disease Progression
Supplemental figure 2 from An Imbalance in TAZ and YAP Expression in Hepatocellular Carcinoma Confers Cancer Stem Cell–like Behaviors Contributing to Disease Progression Open
Changes in cyclin D1 mRNA expression by TAZ knockdown in HCC cells
View article: Supplemental table 1 from An Imbalance in TAZ and YAP Expression in Hepatocellular Carcinoma Confers Cancer Stem Cell–like Behaviors Contributing to Disease Progression
Supplemental table 1 from An Imbalance in TAZ and YAP Expression in Hepatocellular Carcinoma Confers Cancer Stem Cell–like Behaviors Contributing to Disease Progression Open
Characteristics of 110 patients with hepatocellular carcinoma
View article: Supplemental table 1 from An Imbalance in TAZ and YAP Expression in Hepatocellular Carcinoma Confers Cancer Stem Cell–like Behaviors Contributing to Disease Progression
Supplemental table 1 from An Imbalance in TAZ and YAP Expression in Hepatocellular Carcinoma Confers Cancer Stem Cell–like Behaviors Contributing to Disease Progression Open
Characteristics of 110 patients with hepatocellular carcinoma
View article: Supplemental figure 4 from An Imbalance in TAZ and YAP Expression in Hepatocellular Carcinoma Confers Cancer Stem Cell–like Behaviors Contributing to Disease Progression
Supplemental figure 4 from An Imbalance in TAZ and YAP Expression in Hepatocellular Carcinoma Confers Cancer Stem Cell–like Behaviors Contributing to Disease Progression Open
YAP knockdown in other gastrointestinal cancer cells (SW620 and TE-1 cells) with high YAP expression.
View article: Supplemental methods from An Imbalance in TAZ and YAP Expression in Hepatocellular Carcinoma Confers Cancer Stem Cell–like Behaviors Contributing to Disease Progression
Supplemental methods from An Imbalance in TAZ and YAP Expression in Hepatocellular Carcinoma Confers Cancer Stem Cell–like Behaviors Contributing to Disease Progression Open
Supplemental methods
View article: Supplemental figure 1 from An Imbalance in TAZ and YAP Expression in Hepatocellular Carcinoma Confers Cancer Stem Cell–like Behaviors Contributing to Disease Progression
Supplemental figure 1 from An Imbalance in TAZ and YAP Expression in Hepatocellular Carcinoma Confers Cancer Stem Cell–like Behaviors Contributing to Disease Progression Open
Knockdown of TAZ or YAP expression by siRNA duplex oligonucleotides.
View article: Supplemental table 2 from An Imbalance in TAZ and YAP Expression in Hepatocellular Carcinoma Confers Cancer Stem Cell–like Behaviors Contributing to Disease Progression
Supplemental table 2 from An Imbalance in TAZ and YAP Expression in Hepatocellular Carcinoma Confers Cancer Stem Cell–like Behaviors Contributing to Disease Progression Open
Association between TAZ or YAP mRNA expression and patient's characteristics in hepatocellular carcinoma
View article: Data from An Imbalance in TAZ and YAP Expression in Hepatocellular Carcinoma Confers Cancer Stem Cell–like Behaviors Contributing to Disease Progression
Data from An Imbalance in TAZ and YAP Expression in Hepatocellular Carcinoma Confers Cancer Stem Cell–like Behaviors Contributing to Disease Progression Open
Transcriptional coactivator with PDZ-binding motif (TAZ) and yes-associated protein (YAP) are equivalently placed downstream effectors of the Hippo pathway with oncogenic roles in human cancers. However, the expression profiles of TAZ/YAP …
View article: Supplemental figure 5 from An Imbalance in TAZ and YAP Expression in Hepatocellular Carcinoma Confers Cancer Stem Cell–like Behaviors Contributing to Disease Progression
Supplemental figure 5 from An Imbalance in TAZ and YAP Expression in Hepatocellular Carcinoma Confers Cancer Stem Cell–like Behaviors Contributing to Disease Progression Open
qPCR analysis of EpCAM, CD133, and CD44 expressions in response to TAZ knockdown.
View article: Supplemental figure 1 from An Imbalance in TAZ and YAP Expression in Hepatocellular Carcinoma Confers Cancer Stem Cell–like Behaviors Contributing to Disease Progression
Supplemental figure 1 from An Imbalance in TAZ and YAP Expression in Hepatocellular Carcinoma Confers Cancer Stem Cell–like Behaviors Contributing to Disease Progression Open
Knockdown of TAZ or YAP expression by siRNA duplex oligonucleotides.
View article: Supplemental methods from An Imbalance in TAZ and YAP Expression in Hepatocellular Carcinoma Confers Cancer Stem Cell–like Behaviors Contributing to Disease Progression
Supplemental methods from An Imbalance in TAZ and YAP Expression in Hepatocellular Carcinoma Confers Cancer Stem Cell–like Behaviors Contributing to Disease Progression Open
Supplemental methods
View article: Supplemental table 2 from An Imbalance in TAZ and YAP Expression in Hepatocellular Carcinoma Confers Cancer Stem Cell–like Behaviors Contributing to Disease Progression
Supplemental table 2 from An Imbalance in TAZ and YAP Expression in Hepatocellular Carcinoma Confers Cancer Stem Cell–like Behaviors Contributing to Disease Progression Open
Association between TAZ or YAP mRNA expression and patient's characteristics in hepatocellular carcinoma
View article: Supplemental figure 2 from An Imbalance in TAZ and YAP Expression in Hepatocellular Carcinoma Confers Cancer Stem Cell–like Behaviors Contributing to Disease Progression
Supplemental figure 2 from An Imbalance in TAZ and YAP Expression in Hepatocellular Carcinoma Confers Cancer Stem Cell–like Behaviors Contributing to Disease Progression Open
Changes in cyclin D1 mRNA expression by TAZ knockdown in HCC cells
View article: Supplemental figure 5 from An Imbalance in TAZ and YAP Expression in Hepatocellular Carcinoma Confers Cancer Stem Cell–like Behaviors Contributing to Disease Progression
Supplemental figure 5 from An Imbalance in TAZ and YAP Expression in Hepatocellular Carcinoma Confers Cancer Stem Cell–like Behaviors Contributing to Disease Progression Open
qPCR analysis of EpCAM, CD133, and CD44 expressions in response to TAZ knockdown.
View article: Supplemental figure 3 from An Imbalance in TAZ and YAP Expression in Hepatocellular Carcinoma Confers Cancer Stem Cell–like Behaviors Contributing to Disease Progression
Supplemental figure 3 from An Imbalance in TAZ and YAP Expression in Hepatocellular Carcinoma Confers Cancer Stem Cell–like Behaviors Contributing to Disease Progression Open
Effects of YAP overexpression on phosphorylation of Erk1/2 in HuH1 cells.
View article: Supplementary Figure Legends from An Imbalance in TAZ and YAP Expression in Hepatocellular Carcinoma Confers Cancer Stem Cell–like Behaviors Contributing to Disease Progression
Supplementary Figure Legends from An Imbalance in TAZ and YAP Expression in Hepatocellular Carcinoma Confers Cancer Stem Cell–like Behaviors Contributing to Disease Progression Open
Supplementary Figure Legends
View article: Supplemental figure 3 from An Imbalance in TAZ and YAP Expression in Hepatocellular Carcinoma Confers Cancer Stem Cell–like Behaviors Contributing to Disease Progression
Supplemental figure 3 from An Imbalance in TAZ and YAP Expression in Hepatocellular Carcinoma Confers Cancer Stem Cell–like Behaviors Contributing to Disease Progression Open
Effects of YAP overexpression on phosphorylation of Erk1/2 in HuH1 cells.
View article: High-flow nasal cannula for severe COVID-19 patients in a Japanese single-center, retrospective, observational study: 1 year of clinical experience
High-flow nasal cannula for severe COVID-19 patients in a Japanese single-center, retrospective, observational study: 1 year of clinical experience Open
High-flow nasal cannula (HFNC) can be effective in treating type 1 respiratory failure by reducing the severity of coronavirus disease 2019 (COVID-19). The purpose of this study was to assess the reduction of disease severity and safety of…
View article: Clinical usefulness of end‐tidal CO<sub>2</sub> measured using a portable capnometer in patients with respiratory disease
Clinical usefulness of end‐tidal CO<sub>2</sub> measured using a portable capnometer in patients with respiratory disease Open
Introduction This study aimed to evaluate the correlation and agreement between end‐tidal CO 2 (EtCO 2 ) measured with the novel portable capnometer (CapnoEye®) and partial pressure of arterial carbon dioxide (PaCO 2 ) levels in patients w…